See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Donald Trump
Baseball
Nintendo
Natural Disasters
Social Media
European Union
Trade War
Republican Party
Taxes
Democratic Party
Senate
Published • loading... • Updated

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile

Summary by Joplin Globe
VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology") in combination with…

4 Articles

All
Left
2
Center
Right
Joplin GlobeJoplin Globe
Reposted by
Corsicana Daily SunCorsicana Daily Sun
Lean Left

Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile

VANCOUVER, BC / ACCESS Newswire / March 26, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its second-generation nanoparticle formulation of Polynucleotide Kinase 3'-Phosphatase (PNKP) Compound (the "Technology") in combination with…

Read Full Article
portaldoriograndense.comportaldoriograndense.com

Nanoparticle Breakthrough: A New Dawn in Cancer Treatment?

The University of Alberta presents significant advancements in cancer therapy through a new nanoparticle formulation of the PNKP compound. Onco-Innovations’ study shows that when this compound is combined with radiation therapy, it effectively targets cancer cells while minimizing damage to healthy tissues. The preclinical study notes low toxicity, with treated mice showing no significant side effects, suggesting potential for reduced side effec…

Read Full Article
stocktitan.netstocktitan.net

Cancer Treatment Breakthrough: Zero Toxicity Reported in Radiation Therapy Enhancement Study

Latest preclinical data reveals revolutionary PNKP technology effectively targets cancer cells with unprecedented safety profile. Full analysis of treatment implications inside.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Wednesday, March 26, 2025.
Sources are mostly out of (0)

Similar News Topics

University of Alberta

University of Alberta

Vancouver, British Columbia

Vancouver, British Columbia

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal